Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Expenses (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Accumulated Expenses data on record, last reported at $2.1 million in Q3 2021.

  • For Q3 2021, Accumulated Expenses fell 62.89% year-over-year to $2.1 million; the TTM value through Sep 2021 reached $2.1 million, down 62.89%, while the annual FY2020 figure was $4.8 million, 32.98% down from the prior year.
  • Accumulated Expenses reached $2.1 million in Q3 2021 per COGT's latest filing, up from $1.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $8.2 million in Q1 2021 and bottomed at $357000.0 in Q1 2018.
  • Average Accumulated Expenses over 4 years is $4.5 million, with a median of $5.5 million recorded in 2020.
  • Peak YoY movement for Accumulated Expenses: surged 1599.44% in 2019, then crashed 77.57% in 2021.
  • A 4-year view of Accumulated Expenses shows it stood at $5.5 million in 2018, then skyrocketed by 30.2% to $7.1 million in 2019, then plummeted by 32.98% to $4.8 million in 2020, then tumbled by 57.02% to $2.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $2.1 million in Q3 2021, $1.3 million in Q2 2021, and $8.2 million in Q1 2021.